Skip to main content
Erschienen in: Familial Cancer 1/2021

20.07.2020 | Short Communication

Multiple primary cancers (renal papillary, lymphoma and teratoma) and hepatic cysts in association with a pathogenic germline mutation in the MET gene

verfasst von: Julian Adlard

Erschienen in: Familial Cancer | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Activating germline mutations of the MET gene are associated with hereditary papillary renal cancer. This a very rare autosomal dominant condition, which is usually considered not to display a phenotype of multiple types of malignancy. However, this report describes the case of a man who has been affected with testicular teratoma, diffuse large B-cell lymphoma and multiple hepatic cysts, as well as multiple papillary renal cancers. There is good supporting evidence for roles of over-expression/activity of the HGF/MET ligand-receptor in development of these tumours, raising the possibility of other increased cancer risks associated with activating germline MET gene mutations.
Literatur
1.
Zurück zum Zitat Schmidt L, Duh F, Chen F et al (1997) Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16:68–73CrossRef Schmidt L, Duh F, Chen F et al (1997) Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16:68–73CrossRef
2.
Zurück zum Zitat Carlo MI, Hakimi AA, Stewart GD et al (2019) Familial kidney cancer: implications of new syndromes and molecular insights. Eur Urol 76:754–764CrossRef Carlo MI, Hakimi AA, Stewart GD et al (2019) Familial kidney cancer: implications of new syndromes and molecular insights. Eur Urol 76:754–764CrossRef
3.
Zurück zum Zitat Tovar EA, Graveel CR (2017) MET in human cancer: germline and somatic mutations. Ann Transl Med 5:205CrossRef Tovar EA, Graveel CR (2017) MET in human cancer: germline and somatic mutations. Ann Transl Med 5:205CrossRef
6.
Zurück zum Zitat Ricci G, Catizone A (2014) Pleiotropic activities of HGF/c-Met system in testicular physiology: paracrine and endocrine implications. Front Endocrinol 5:38CrossRef Ricci G, Catizone A (2014) Pleiotropic activities of HGF/c-Met system in testicular physiology: paracrine and endocrine implications. Front Endocrinol 5:38CrossRef
7.
Zurück zum Zitat Scheri KC, Leonetti E, Laino L et al (2018) c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors. Oncotarget 9:31842–31860CrossRef Scheri KC, Leonetti E, Laino L et al (2018) c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors. Oncotarget 9:31842–31860CrossRef
8.
Zurück zum Zitat Das MK, Kleppa L, Haugen TB (2019) Functions of genes related to testicular germ cell tumour development. Andrology 7:527–535CrossRef Das MK, Kleppa L, Haugen TB (2019) Functions of genes related to testicular germ cell tumour development. Andrology 7:527–535CrossRef
9.
Zurück zum Zitat Zeh N, Wild PJ, Bode PK et al (2013) Retroperitoneal teratoma with somatic malignant transformation: a papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapy. BMC Urol 13:9CrossRef Zeh N, Wild PJ, Bode PK et al (2013) Retroperitoneal teratoma with somatic malignant transformation: a papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapy. BMC Urol 13:9CrossRef
10.
Zurück zum Zitat van der Voort R, Taher TE, Derksen PW et al (2000) The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation. Adv Cancer Res 79:39–90CrossRef van der Voort R, Taher TE, Derksen PW et al (2000) The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation. Adv Cancer Res 79:39–90CrossRef
11.
Zurück zum Zitat Uddin S, Hussain AR, Ahmed M et al (2010) Inhibition of c-MET is a potential therapeutic strategy for treatment of diffuse large B-cell lymphoma. Lab Invest 90:1346–1356CrossRef Uddin S, Hussain AR, Ahmed M et al (2010) Inhibition of c-MET is a potential therapeutic strategy for treatment of diffuse large B-cell lymphoma. Lab Invest 90:1346–1356CrossRef
12.
Zurück zum Zitat Lam BQ, Dai L, Qin Z (2016) The role of HGF/c-MET signaling pathway in lymphoma. J Hematol Oncol 9:135CrossRef Lam BQ, Dai L, Qin Z (2016) The role of HGF/c-MET signaling pathway in lymphoma. J Hematol Oncol 9:135CrossRef
13.
Zurück zum Zitat Bouattour M, Raymond E, Qin S et al (2018) Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma. Hepatology 67:1132–1149CrossRef Bouattour M, Raymond E, Qin S et al (2018) Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma. Hepatology 67:1132–1149CrossRef
14.
Zurück zum Zitat Graveel CR, DeGroot JD, Sigler RE et al (2010) Germline met mutations in mice reveal mutation - and background-associated differences in tumor profiles. PLoS ONE 5(10):e13586CrossRef Graveel CR, DeGroot JD, Sigler RE et al (2010) Germline met mutations in mice reveal mutation - and background-associated differences in tumor profiles. PLoS ONE 5(10):e13586CrossRef
15.
Zurück zum Zitat El Bouchtaoui M, Do Cruzeiro M, Leboeuf C et al (2019) A constitutional activating MET mutation makes the genetic link between malignancies and chronic inflammatory diseases. Clin Cancer Res 25:4504–4515CrossRef El Bouchtaoui M, Do Cruzeiro M, Leboeuf C et al (2019) A constitutional activating MET mutation makes the genetic link between malignancies and chronic inflammatory diseases. Clin Cancer Res 25:4504–4515CrossRef
16.
Zurück zum Zitat Chen JD, Kearns S, Porter T et al (2001) MET mutation and familial gastric cancer. J Med Genet 38(8):E26CrossRef Chen JD, Kearns S, Porter T et al (2001) MET mutation and familial gastric cancer. J Med Genet 38(8):E26CrossRef
17.
Zurück zum Zitat Toledo RA, Qin Y, Cheng ZM et al (2016) Recurrent mutations of chromatin-remodeling genes and kinase receptors in pheochromocytomas and paragangliomas. Clin Cancer Res 22:2301–2310CrossRef Toledo RA, Qin Y, Cheng ZM et al (2016) Recurrent mutations of chromatin-remodeling genes and kinase receptors in pheochromocytomas and paragangliomas. Clin Cancer Res 22:2301–2310CrossRef
18.
Zurück zum Zitat Whitworth J, Skytte AB, Sunde L et al (2016) Multilocus inherited neoplasia alleles syndrome: a case series and review. JAMA Oncol 2:373–379CrossRef Whitworth J, Skytte AB, Sunde L et al (2016) Multilocus inherited neoplasia alleles syndrome: a case series and review. JAMA Oncol 2:373–379CrossRef
Metadaten
Titel
Multiple primary cancers (renal papillary, lymphoma and teratoma) and hepatic cysts in association with a pathogenic germline mutation in the MET gene
verfasst von
Julian Adlard
Publikationsdatum
20.07.2020
Verlag
Springer Netherlands
Erschienen in
Familial Cancer / Ausgabe 1/2021
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-020-00196-z

Weitere Artikel der Ausgabe 1/2021

Familial Cancer 1/2021 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.